Gene targeting using embryonal stem cells has been used to generate strains of mice with inactivating mutations at the Rb-1 and p53 tumour suppressor loci. Mice heterozygous for a null allele of Rb-1 do not show retinoblastomas but instead develop pituitary tumours. Homozygotes die at between 10 and 14 days' gestation and show increased levels of both cell division and cell death by apoptosis in the haematopoietic and nervous systems. This is consistent with the view that the Rb-1 gene product plays a general role in the maturation of precursor cells. In contrast, mice het erozygous for a null allele of p53 are predisposed to a spectrum of tumours, while the corresponding homozygotes are viable but show a very high tumour incidence. Thymo cytes from p53 homozygotes, unlike wild-type thymocytes, do not show increased levels of apoptosis following treatment with DNA-damaging agents, while response to its induction by other agents is unaltered. Similarly, epithelial cells from the crypts of both small and large intestine of p53-dehcient mice are resistant to the induction of apoptosis by y-irradiation. In contrast, two other early responses of wild type crypts to y-irradiation, namely the G2 block and the reduction in bromodeoxyuridine incorporation, are both largely intact in p53-deficient mice. These observations are consistent with the view that p53 is responsible for moni toring DNA damage so that damaged cells can be either repaired or eliminated prior to division.
INTRODUCTION
An oncosuppressor gene is one whose normal function prevents the development of one or more types of cancer; such genes are also known as tumour suppressor genes or antioncogenes (reviewed by Knudson, 1993) . A powerful way of investigat ing how such genes function is to examine the consequences of inactivating them in an experimental animal. This can be done using gene targeting in embryonal stem (ES) cells (reviewed by Hooper, 1992) . These cells, established in culture from the pluripotent inner cell mass cells of the peri-implantation embryo, retain the capacity to colonise the somatic tissues and germ line of chimaeras produced by injecting them into blastocyst-stage embryos. Designed mutations can be introduced into chosen genes by introducing into the cultured cells a gene targeting DNA vector and isolating cells in which the vector has undergone homologous recombination with the endogenous gene. These mutations can then be introduced via chimaeras into the mouse germ line. I will describe the application of this approach to the Rb-1 and p53 oncosuppressor genes.
THE RB-1 GENE
The paradigm for oncosuppressor genes is the retinoblastoma susceptibility gene RB-1. Retinoblastoma is a tumour of the retina occurring predominantly in early childhood which, although relatively uncommon, is of interest in that about 40% of all cases are familial. Knudson (1971) proposed that these tumours arise as a result of two mutational events, of which one is present in the germline in familial cases. Recent molecular analysis has shown this to be correct, and demon strated that both events involve modification or loss of the same gene, RB-1. More than 90% of individuals constitutively heterozygous for an RB-1 mutation develop retinoblastoma as a result of a somatic event occurring in one or more cells of the retina, or of its precursor tissues, that eliminates the function of the wild-type allele, usually by allele loss (reviewed by Knudson, 1993) . The exact cell type of origin of retinoblastoma is the subject of some dispute, with advocates of primitive neurotubular cell, glial cell and photoreceptor cell origin, the last possibility being most easily reconcilable with biochemical, immunocytochemical and morphological proper ties (Rootman et al., 1987) . Photoreceptor-like ultrastructural features are particularly marked in benign tumours, termed retinomas or retinocytomas, which develop in a small propor tion of RB-1 heterozygotes and are thought to result from loss of the residual wild-type allele in a more mature stage of the retinoblastoma precursor cell type (Gallie et al., 1982) . These tumours have been described as cone-like (Margo et al., 1983) , although this should not be over-interpreted since the organi sational features that distinguish rods from cones would probably be obscured in a tumour. In addition to retinal tumours, about 15% of RB-1 heterozygotes develop osteosar comas. RB-1 allele loss is also seen in sporadic lung, breast, prostate and bladder carcinomas, although no increase in incidence of these tumours is seen in germline heterozygotes (see Knudson, 1993 ).
The RB-1 gene codes for a 105 kD a protein that is present in m ost cell types and undergoes cell cycle-dependent changes in phosphorylation as a result o f the action o f cyclin-dependent kinase and phosphoprotein phosphatase activity (see H ollingsw orth et al., 1993) . T he hypophosphorylated protein associates w ith the cell nucleus and binds to transcription factors such as E2F, w ith effects that depend upon the tran scription factor and in som e cases also on the cell type. T ran scription o f genes containing an E2F recognition site is inhibited by the binding o f the RB-1 gene product; such genes include several w hose products are required during S phase. It appears to depend upon the phase o f the cell cycle w hether E2F is predom inantly associated w ith the RB-1 gene product or w ith one o f two other related proteins, p i 07 or p i 30 (Cao et al., 1992; S hirodkar et al., 1992; Li et al., 1993; H annon et al., 1993; C obrinik et al., 1993) and it is likely that this provides a further level at w hich the expression o f E 2F-dependent genes can be regulated. A different control elem ent is im plicated in the stim ulation o f c-fos expression by the RB-1 gene product (Robbins et al., 1990) . F urther levels o f com plexity m ay be present in the form of feedback control loops, one involving RB-1 and T G F -P l possibly involved in the regulation o f c-m yc expression (see H ollingsw orth et al., 1993) and another involving RB-1 and a cyclin-dependent kinase inhibitor, pjgiNK4 (Serrano et al., 1993) . N um erous proteins other than transcription factors also associate with the RB-1 gene product, im plicating it in m echanism s unrelated to the control o f gene expression. T he im portance o f RB-1 in cell cycle regulation is em phasised by the fact that several tum our viruses have inde pendently evolved proteins that bind to the hypophosphory lated gene product and thus inactivate it, exam ples being SV 40 T antigen, adenovirus E l A protein and hum an papillom avirus E7 protein (see H ollingsw orth et al., 1993).
R b -1 MUTANT MICE
The corresponding m urine gene, designated Rb-1, has 91% sequence hom ology to the hum an gene and is widely expressed in m ouse tissues (Bernards et al., 1989; Szekely et al., 1992) . In collaboration w ith the laboratory of D r A nton Berns at the N etherlands C ancer Institute, w e have used gene targeting to introduce m utations into the m ouse Rb-1 gene (Clarke et al., 1992) . Tw o other groups have also done so (Lee et al., 1992; Jacks et al., 1992) . All three groups have reported sim ilar results, and in w hat follow s I will discuss principally our own data, with reference to those o f the other groups w here appro priate. W e used two targeting vectors to generate the m utant Rb-1 alleles, designed to insert, respectively, the selectable m arker genes neo and hyg, in each case u nder the control o f the pgk-1 prom oter, into exon 19 o f the Rb-1 gene (C larke et al., 1992) . Both insertions carry translation term ination codons in all three reading fram es and polyadenylation signals, so that in the targeted allele the Rb-1 reading fram e is truncated upstream of the coding sequences for SV 40 T antigen-binding dom ain num ber 2, w hich is essential for the function o f the gene product (Hu et al., 1990) . W e therefore consider both targeted alleles as null alleles.
In contrast to the situation in hum ans, no retinoblastom as have to date been detected in m ice heterozygous for a null allele o f Rb-1. W e have considered a num ber o f possible expla nations for this. First, because o f their sm aller size and shorter lifespan, m ice may sim ply have a low er probability o f a som atic m utation occurring in the retina during the period w hen it is susceptible to tum our developm ent, so that only a very small proportion o f heterozygotes develop retinoblas tom as. H ow ever, as the aggregate num ber o f heterozygous anim als exam ined by the three groups increases, this hypothe sis becom es progressively less tenable. Second, m ice may differ from hum ans in the level o f exposure o f their retinas to som e required environm ental agent. A s laboratory m ice are m aintained under conditions o f artificial light and are active principally in the hours o f darkness, one candidate for such an environm ental agent is sunlight. Intriguingly, published inci dences o f hum an retinoblastom a are significantly correlated w ith geographical latitude ( Fig. 1 ) and m ore recent data also show this trend (M. L. H ooper and D. M. Parkin, unpublished), indicating that this hypothesis is w orthy o f further investiga F ig. 1. Effect of geographical latitude on retinoblastom a incidence. Agestandardised rates for the first 14 years of life are taken from Parkin et al. (1988) . A linear regression has been fitted to the data using the GLIM statistical package (Numerical Algorithms Group, Oxford). The slope, -0.02606 ± s.e. 0.01158, is significantly different from zero (r=2.250, /-'<0.05).
latitude (degrees N or S) tion. Third, there may be a need in the mouse for an additional genetic event or events. Two observations suggest that this idea should be taken seriously: (i) retinoblastomas are uncommon if not non-existent in veterinary practice (Hogan and Albert, 1991) , suggesting that humans may be unusually susceptible; (ii) it is possible to induce retinoblastoma in the mouse by expressing SV40 T antigen in the retina, thereby inactivating both the Rb-1 and p53 gene products (Windle et al., 1990) . However, crossing into our Rb-1 mutant stock the null allele of p53 described below has not led to the development of any retinoblastomas (A. R. Clarke et al., unpublished observa tions). Fourth, in view of the relationship to photoreceptor cells discussed above, it may be significant that the photoreceptors of the predominantly nocturnal mouse are almost exclusively rods, while humans also possess cones of three different spectral sensitivities (see Bowmaker, 1991) . Notwithstanding the absence of retinoblastomas in Rb-1 heterozygous mice, pituitary adenocarcinomas develop in most if not all of these animals (Jacks et al., 1992; Hu et al., 1994 ; D. J. Harrison et al., unpublished observations). Hu et al. (1994) report that these tumours develop in the intermediate lobe of the pituitary, which is present only in vestigial form in adult humans. They produce a-melanocyte stimulating hormone, suggesting that they originate from corticotrope cells and, interestingly, also show patchy expression of the photoreceptor S-antigen (Hu et al., 1994) .
No instance of constitutional homozygosity for a null RB-1 allele has been reported in humans, and so the production of Rb-1 mutant mice allowed the consequences of germline homozygosity at this locus to be studied for the first time. When heterozygous mice were intercrossed, no homozygotes survived to term, and examination of midgestation embryos revealed that homozygotes showed abnormalities in the haematopoietic and nervous systems, in both cases involving increased levels of cell death by apoptosis and overabundant or ectopic mitosis (Clarke et al., 1992; Lee et al., 1992; Jacks et al., 1992) . The tissues affected correlate well with sites of high-level Rb-1 expression (Szekely et al., 1992) and are those in which maturation of a dividing precursor cell population to a postmitotic differentiated cell occurs earliest in embryonic development, suggesting that Rb-1 has a generalised role in the maturation of precursor cells. The presence of abnormalities in both cell division and cell death is consistent with the hypoth esis that Rb-1 functions to maintain cells in a quiescent state in which they show reduced levels of both mitosis and apoptosis (Dive and Wyllie, 1993) . Interestingly, at least part of the /^-/-deficient phenotype appears not to be cellautonomous, since Rb-1 -deficient embryonal stem cells can give rise to phenotypically normal mature B and T lympho cytes in chimaeras produced by injecting them into blastocysts homozygous for a mutation in the Rag-2 gene (Chen et al., 1993) .
•
THE p 5 3 GENE
The p53 gene, originally discovered by virtue of its ability to form a complex with SV40 T antigen (Lane and Crawford, 1979) , was at first thought to be an oncogene, but it was sub sequently realised that the allele initially cloned and studied was, in fact, a mutant allele, and the wild-type gene functions as an oncosuppressor (see Knudson, 1993) . Its loss is the most common allele loss in human malignancy, and germline het erozygosity for a mutant allele causes Li-Fraumeni syndrome, a predisposition to a spectrum of tumours of which breast and brain tumours are the most common (reviewed by Knudson, 1993) . The gene encodes a sequence-specific DNA-binding protein that activates the expression of a reporter gene adjacent to the binding site (reviewed by Vogelstein and Kinzler, 1992) . The protein is phosphorylated in a cell cycle-dependent manner, and following DNA damage its levels rise as a result of post-translational stabilisation, leading to Gi growth arrest. It has been shown recently that the Gi arrest is mediated by a 21 kDa cyclin-dependent kinase inhibitor, variously designated WAF-1, Cip-1 or sdi-1, whose expression is induced by p53 protein (reviewed by Nasmyth and Hunt, 1993) . Loss of wild type p53 is associated with genomic instability, which has led to the proposal that the p53 protein functions to prevent cells entering S phase before DNA damage has been repaired (Lane, 1992) . Studies on cultured cell lines have also implicated p53 in the regulation of apoptosis (Yonish-Rouach et al., 1991; Shaw et al., 1992) . Some mutant alleles of p53 exert a dominant negative effect and are able, in the presence of wild type p53, to immortalise normal early-passage cells in culture and cooperate with ras to induce transformation of embryo fibroblasts. This effect depends on the ability of the mutant protein to sequester wild-type protein into inactive oligomers. Such alleles lack the ability of the wild-type allele to suppress the transformation of embryo fibroblasts by other oncogenes, which is itself not dependent on ability to oligomerise (see Slingerland et al., 1993) .
p53 MUTANT MICE
Mice with a targeted mutation in the p53 gene were first reported by Donehower et al. (1992) , who found that het erozygous animals developed tumours at low frequency, while homozygotes developed normally to birth but all developed tumours, of various types, in the first few months of life. Although the targeted allele carried by these mice was designed as a null allele, the possibility could not be rigorously excluded that an active polypeptide fragment could be produced from the 3' end of the modified gene. However, we have used gene targeting to produce mice with a p53 allele in which exons 2 to 6 are replaced by an insert that, as described above for Rb-1, truncates the reading frame, producing an unambiguously null allele (Clarke et al., 1993) , and these mice behave similarly. Homozygous mice develop tumours, pre dominantly T cell lymphomas, during the first six months of life; in heterozygotes, which develop tumours later, soft tissue sarcomas are relatively more important (Purdie et al., 1994) . Some mice developed pathological signs without obvious tumour development, and most of these showed reactive lymphoid hyperplasia, suggesting a perturbation of the immune system. A similar tumour spectrum has been reported in a third p53 mutant strain (Jacks et al., 1994) . Small differences in tumour spectrum between strains are probably a consequence of differences in genetic background (Harvey et al., 1993a) . Most tumours in our p53 heterozygotes had suffered loss of the wild-type p53 allele, indicating that the gene behaves as a classical oncosuppressor. In contrast to the pituitary tumours Clarke et al., 1993) .
occurring in the Rb-1 heterozygotes, most of the tumours in p53 heterozygous and homozygous mice contained an aneuploid or polyploid cell population as assessed by flow cytometry, consistent with the concept that, in the absence of functional p53, cells enter division without having repaired DNA damage, and this leads to abnormalities in chromosome segregation (Lane, 1992 ). An important clue to the mechanism underlying the tumour suppressor activity of p53 was provided by studies of thymocyte apoptosis. Wild-type thymocytes placed in culture in serum-free medium spontaneously undergo apoptosis over a 1-to 2-day period, and the rate of this apoptosis can be stim ulated by a variety of stimuli including physiological agents such as glucocorticoids and DNA-damaging agents such as yradiation. Thymocytes from p53 homozygous mice showed normal response to agents of the former class, but were resistant to induction of apoptosis by agents of the second class (Clarke et al., 1993; Lowe et al., 1993b) . Heterozygous cells showed an intermediate response. This suggested that stimuli can feed into the apoptosis pathway via different routes, and that p53 is required in a branch route linking DNA damage to the main apoptosis pathway (Fig. 2) .
In order to investigate whether this behaviour is peculiar to thymocytes, we have also examined the response of epithelial cells of intestinal crypts to y-irradiation in vivo. Four hours after irradiation, crypt cells from both small intestine and colon of wild-type mice showed abundant apoptosis, but corre sponding cells from p53 homozygotes were completely resistant to induction of apoptosis. Again, cells from het erozygotes showed an intermediate response. In contrast, two other early responses of wild-type crypts to y-irradiation, namely reduction in the proportion of cells in S phase, as assessed by the bromodeoxyuridine labelling index, and growth arrest in the G2 phase of the cell cycle (reviewed by Potten, 1990) were both largely intact in /?53-deficient animals . Merritt et al. (1994) also observed resis tance of intestinal epithelial cells from p53 homozygous mutant mice to induction of apoptosis by y-irradiation, although they did not observe a reduction in the response of cells from heterozygotes, perhaps because they used a higher irradiation dose. In both studies the low background level of apoptosis in the intestine appeared to be p55-independent, indi cating that, as with thymocytes, p53 is required to link apoptosis to DNA damage rather than being required for apoptosis per se. This is consistent with the observation that the development of homozygous /^53-deficient mice to birth is normal, implying no anomalies in developmental programmed cell death (Donehower et al., 1992) , and with the finding that p53 is not required for the apoptosis that occurs in prostatic glandular cells following androgen ablation (Berges et al., 1993) .
An important question that remains is that of how cells make a decision between different /j5J-mediated responses to DNA damage, i.e. a decision between entry into growth arrest, thereby possibly allowing DNA repair, and entry into apoptosis. Relevant to this question is recent work of Lowe et al. (1993a) who showed, using fibroblasts of different p53 genotypes, that the apoptotic response in these cells is seen only when Gi growth arrest is bypassed by expressing the adenovirus E l A protein in the cells, suggesting that in general the choice of response depends upon what other genes the cell is expressing. Fibroblasts from p53 mutant mice have also been used to confirm that p53-deficiency promotes genetic instability and to show that it facilitates immortalisation (Harvey et al., 1993b) . Enhanced proliferative potential has been noted in a variety of cell types from pJ3-deficient mice (Tsukuda et al., 1993) .
It seems reasonable to conclude that the reason that p53-deficient mice develop tumours is that damaged, potentially tumourigenic cells fail to be eliminated by the normal apoptotic pathway and instead grow into tumours. This emphasises the fact that the regulation of cell death can be as important as the regulation of cell division in determining whether tumours develop. It also has implications for cancer therapy in that some anti-cancer drugs appear to exert their cytotoxic effect by induction of the endogenous apoptotic pathway (reviewed by Dive and Wyllie, 1993) and therefore loss of p53, the most common allele loss in human cancer, may be an important mechanism of resistance to such drugs. The advent of novel drugs specifically designed to activate the natural suicide pathway of the cell is likely to provide valuable therapeutic agents for the treatment of cancer in future years.
